Consistent with other postmortem data indicating that greater than 60-80% of striatal dopamine loss is necessary for overt motor symptoms to occur52), the maximal 44% dopamine reduction in the striatum of the asymptomatic GCH1 mutation carrier was not sufficient to produce any symptoms of GTPCH-deficient DRD. The gene discussed is GCH1; the disease is dystonia 5.